Pinsaguel, France

Lo Ic Foulon

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lo Ic Foulon. Retrieved from https://idiyas.com/inventor/lo-ic-foulon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lo Ic Foulon: Innovator in Pharmaceutical Chemistry

Introduction

Lo Ic Foulon is a notable inventor based in Pinsaguel, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on specific chemical derivatives. His research focuses on compounds that have potential therapeutic applications.

Latest Patents

Foulon holds a patent for 1-benzyl-1,3-dihydroindol-2-one derivatives. This invention relates to the preparation of these derivatives, which are characterized by their affinity for vasopressin and oxytocin receptors. The patent outlines the formula (I) for these compounds and discusses their potential use in pharmaceutical compositions.

Career Highlights

Throughout his career, Lo Ic Foulon has been associated with Sanofi, a leading global healthcare company. His work has contributed to advancements in drug development and therapeutic solutions. Foulon's expertise in chemical synthesis and pharmacology has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Foulon has collaborated with esteemed colleagues such as Georges Garcia and Claudine Serradeil-Legal. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Lo Ic Foulon's contributions to pharmaceutical chemistry through his patented inventions demonstrate his commitment to advancing medical science. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…